Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study

Cancer Treat Rep. 1987 Apr;71(4):427-8.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Clinical Trials as Topic
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Metastasis

Substances

  • Doxorubicin
  • esorubicin